Carone F A, Peterson D R, Flouret G
J Lab Clin Med. 1982 Jul;100(1):1-14.
Reabsorption and/or degradation of proteins or peptides are functions of the proximal tubule. Large polypeptides or proteins are reabsorbed by luminal endocytosis and hydrolyzed by lysosomal enzymes. Our recent studies indicate that small linear peptides are hydrolyzed at the luminal membrane, with reabsorption of metabolites. The renal transport and hydrolysis of radiolabeled Al, All, BKN, oxytocin, glucagon, insulin, and LHRH were studied. Techniques for in vivo microinfusion of surface tubules in rats, arterial infusion in filtering and nonfiltering rat kidneys in vivo, and in vitro microperfusion of isolated rabbit nephron segments were used. Reabsorption of radiolabeled material was measured and the intact peptide or its metabolites were identified and quantified in urine, renal venous blood, bathing medium, and/or collection fluid. In addition, peptides were incubated in the presence of isolated renal membrane preparations to identify a probably cellular site of hydrolysis. The findings indicate that in proximal, but not distal tubules, radiolabeled Al, All, BKN, glucagon, and LHRH are hydrolyzed by brush border enzymes at the luminal membrane, followed by reabsorption of metabolites. In addition, it was found that, similar to the small intestine, the proximal tubule reabsorbed small peptide fragments, which were further degraded intracellurarly, In vivo inhibition studies with excess peptides revealed that hydrolysis is a more specific process than studies with excess peptides revealed that hydrolysis is a more specific process than reabsorption of metabolites. Large or small, complex peptides like insulin, oxytocin, or vasopressin that contain disulfide bridges are not hydrolyzed at the luminal brush border of the proximal tubule. In vivo sequestration and slow degradation of insulin by rat tubules suggest that this peptide is reabsorbed by endocytosis and degraded in lysosomes. Thus, as the molecular complexity or weight of a peptide increases, the mechanism for renal tubular degradation, instead of depending on luminal membrane hydrolysis, may primarily involve endocytosis and lysosomal digestion. This recently described mechanism for hydrolysis and transport of small linear peptides in the proximal nephron is characterized by having a high capacity and is analogous to membrane hydrolysis described for intestinal microvilli. The process may be biologically important to (1) conserve amino acids, (2) inactivate toxic peptides, and (3) help regulate circulating levels of peptide hormones.
蛋白质或肽的重吸收和/或降解是近端小管的功能。大分子多肽或蛋白质通过管腔胞吞作用被重吸收,并被溶酶体酶水解。我们最近的研究表明,小线性肽在管腔膜处被水解,同时代谢产物被重吸收。我们研究了放射性标记的Al、All、BKN、催产素、胰高血糖素、胰岛素和促黄体激素释放激素(LHRH)的肾脏转运和水解过程。采用了大鼠表面小管体内微量灌注技术、体内过滤和非过滤大鼠肾脏的动脉灌注技术以及离体兔肾单位节段的体外微量灌注技术。测定了放射性标记物质的重吸收情况,并对尿液、肾静脉血、灌流液和/或收集液中的完整肽或其代谢产物进行了鉴定和定量。此外,将肽与分离的肾膜制剂一起孵育,以确定可能的细胞水解部位。研究结果表明,在近端小管而非远端小管中,放射性标记的Al、All、BKN、胰高血糖素和LHRH在管腔膜处被刷状缘酶水解,随后代谢产物被重吸收。此外,还发现,与小肠类似,近端小管重吸收小肽片段,这些片段在细胞内进一步降解。用过量肽进行的体内抑制研究表明,水解是一个比代谢产物重吸收更具特异性的过程。含有二硫键的大或小的复杂肽,如胰岛素、催产素或血管加压素,在近端小管的管腔刷状缘处不被水解。大鼠小管对胰岛素的体内隔离和缓慢降解表明,该肽通过胞吞作用被重吸收并在溶酶体中降解。因此,随着肽的分子复杂性或分子量增加,肾小管降解机制可能主要涉及胞吞作用和溶酶体消化,而不是依赖于管腔膜水解。最近描述的近端肾单位中小线性肽的水解和转运机制具有高容量的特点,类似于肠道微绒毛的膜水解。该过程在以下方面可能具有生物学重要性:(1)保存氨基酸;(2)使有毒肽失活;(3)帮助调节肽类激素的循环水平。